Trevi Therapeutics, Inc.
TRVI
Revenue
0.00
0.000.00%
-Assets
73.81M
▼-4.75M▼-6.05%
3 Months ChangeLiabilities
7.64M
▲1.41M▲22.67%
3 Months ChangeFree Cash Flow
-8.25M
▼-4.15M▼-101.07%
48 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-21
Form 8-K
ID: 0000950170-24-115800
2024-10-04
Form 8-K
ID: 0000950170-24-112729
2024-10-01
Form 8-K
ID: 0000950170-24-110462
2024-08-08
Form 10-Q
ID: 0000950170-24-093983
2024-08-08
Form 8-K
ID: 0000950170-24-093942
2024-06-13
Form 8-K
ID: 0000950170-24-073129
2024-05-07
Form 10-Q
ID: 0000950170-24-054489
2024-05-07
Form 8-K
ID: 0000950170-24-054478
2024-03-20
Form 8-K
ID: 0000950170-24-034159
2023-11-09
Form 10-Q
ID: 0000950170-23-062063